NanoNord A/SActive
Key figures
Key ratios
2025/26Balance sheet structure
Financial statements2025–2026
| 2024/25 | 2025/26 | |
|---|---|---|
| Balance sheet — assets | ||
| Cash and cash equivalents | 2.566.000 | 141.000 |
| Total current assets | 38.559.000 | 30.526.000 |
| Total non-current assets | 42.582.000 | 56.208.000 |
| Total assets | 81.141.000 | 86.734.000 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 26.131.000 | 13.825.000 |
| Non-current liabilities | 72.384.000 | 101.670.000 |
| Total liabilities | 98.515.000 | 115.495.000 |
| Share capital | 1.000.000 | 1.000.000 |
| Retained earnings of previous periods | -177.220.000 | -71.612.000 |
| Profit for the year | -9.134.000 | -11.687.000 |
| Total equity | -17.374.000 | -29.061.000 |
| Income statement | ||
| Gross profit | 7.386.000 | 10.398.000 |
| Operating profit | -9.098.000 | -11.862.000 |
| EBITDA | -5.914.000 | -4.359.000 |
| Profit before income tax | -11.429.000 | -15.988.000 |
| Profit for the reporting year | -9.134.000 | -11.687.000 |
| Labour costs | 13.300.000 | 14.757.000 |
| Depreciation of non-current assets | 3.184.000 | 7.503.000 |
| Other indicators | ||
| Employees | 26 | 35 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2026NanoNord has in 2025/26 successfully established the Tveskaeg® Generation 3 NMR sensor as a mature base product, achieving full-scale, high-volume production in close collaboration with our strong network of suppliers. This proven platform is now the backbone of our product line, combining superior measurement quality with highly scalable manufacturing to meet rapidly growing demand. Market momentum remains strong, and sales growth continues on track as planned. This trajectory is supported by a robust pipeline of repeat orders from existing customers for salt measurements in food products, as well as lithium measurements in mining applications. To further enhance our offering and address the increasing market need for automation, we have recently launched Svend—a dedicated autosampler designed to seamlessly complement the Tveskaeg® sensor in automated workflows. At the same time, we continue to expand globally, securing both established multinational clients and a growing base of new customers in our core segments. To support this continued expansion, NanoNord has signed agreements with leading global companies operating in the measurement and quality control space, as well as in farming nutrients and the lithium sector. These partnerships are designed to capture the vast opportunity in the food industry while extending our reach deeper into the agricultural and mining markets. Looking ahead, we are in advanced discussions with additional strategic partners across further in
Loss for the year after tax amounted to DKK 11.7 million. NanoNord continues to invest heavily in the development of low-field industrial NMR technology with the aim of becoming world leading within the field. Management is aware that the Company has lost more than half of the share capital and is thus subject to the capital adequacy rules of section 119 of the Danish Companies Act. In the fiscal year 2025/26, the Company's shareholders have provided loans for a total amount of DKK 25 million. As of 30 april 2026 the total long-term loans from shareholders were DKK 101 million. From June to August 2026, the Company secured their financing through a loan agreement with EIFO for DKK 10 million. Furthermore, the Company entered into loan agreements with its shareholders totaling DKK 16 million. All loan agreements are entered to carry out planned activities and operations in 2026/27. The total financing obtained through the loan agreements subsequent to the financial year-end amounts to DKK 26 million. It is Management's assessment that the operating budget, the budgeted balance sheet and the cash budget for the financial year 2026/27 are realistic, and on this basis, it is Management's assessment that the Company's cash resources are adequate to cover all activities and operations according to the budgets for 2026/27.
Excerpt from the management's review in the latest annual report.